Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P19 - Locoregional and Oligometastatic Disease - Oligometastatic Disease

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P19.01 - Local Ablative Radiotherapy on Oligo-Progression while Continued on EGFR-TKI in Advanced NSCLC Patients: A Longer Cohort

      00:00 - 00:00  |  Presenting Author(s): Florence Siu Ting Mok

      • Abstract

      Loading...

    • +

      P19.02 - Association between Number of Residual Metastases and Patterns of Progression on EGFR TKI in EGFR mutated Non-Small Cell Lung Cancer.

      00:00 - 00:00  |  Presenting Author(s): Taichi Miyawaki

      • Abstract

      Loading...

    • +

      P19.03 - Operative Outcomes of Local Consolidation with Cytoreductive Surgery for Oncogenic-Driven Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Byung Jo Park

      • Abstract

      Loading...

    • +

      P19.04 - Effect of Local Therapy on Survival in Oligometastatic Epidermal Growth Factor Receptor (EGFR) Mutated Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Yu Yang Soon

      • Abstract

      Loading...

    • +

      P19.05 - Postoperative Recurrence of Early-Stage Non-Small Cell Lung Cancer (NSCLC): Clinical Outcomes of Oligo versus Poly-recurrence Disease

      00:00 - 00:00  |  Presenting Author(s): Maria Aimé Giorlando

      • Abstract

      Loading...

    • +

      P19.06 - Radiosurgery followed by Tumor Treating Fields for brain metastases (1-10) from NSCLC in the phase 3 METIS trial

      00:00 - 00:00  |  Presenting Author(s): Minesh P. Mehta

      • Abstract

      Loading...

    • +

      P19.07 - Immune Checkpoint Inhibitors and Additional Local Treatment in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Akin Atmaca

      • Abstract

      Loading...

    • +

      P19.08 - Clinical Outcome of Local Treatment in Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Preliminary Analysis of Prospective Data

      00:00 - 00:00  |  Presenting Author(s): Xiaoxia Zhu

      • Abstract

      Loading...

    • +

      P19.09 - Lung Stereotatic Body Radiation Therapy: Outcomes from a Brazilian Cohort

      00:00 - 00:00  |  Presenting Author(s): LILIAN Faroni

      • Abstract

      Loading...

    • +

      P19.10 - Evaluation of Local Therapy for Oligoprogressive Disease in Metastatic NSCLC Patients on Immunotherapy

      00:00 - 00:00  |  Presenting Author(s): Nicholas Peter Giustini

      • Abstract

      Loading...

    • +

      P19.11 - Endobronchial Brachytherapy as Curative Therapy for Postoperative Intrabronchial Oligometastasis in Non-Small Cell Lung Cancer      

      00:00 - 00:00  |  Presenting Author(s): Atsushi Ito

      • Abstract

      Loading...

    • +

      P19.12 - Immunotherapy as Single Treatment for Brain Metastases of Non-small cell Lung Cancer: A Systematic Review and Meta-Analysis. 

      00:00 - 00:00  |  Presenting Author(s): Viviane Teixeira Loiola de Alencar

      • Abstract

      Loading...

  • +

    P20 - Locoregional and Oligometastatic Disease - Radiation

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P20.01 - Stereotactic Body Radiation Therapy for Residual Primary Lesions after First Line Treatment for Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Lin Zhou

      • Abstract

      Loading...

    • +

      P20.02 - To Evaluate the Efficacy and Optimal Timing of Postoperative Radiotherapy in Completely Resected stage IIIA(N2) Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Wen Feng

      • Abstract

      Loading...

    • +

      P20.03 - Impact of Radiotherapy Timing After Induction Chemotherapy on Survival of Patients With Locally Advanced Non Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Danijela Scepanovic

      • Abstract

      Loading...

    • +

      P20.04 - Dosimetric Comparison of the Real and Virtual Plans in Non-Small Cell Lung Cancer Patients Treated With Respiratory Motion Management

      00:00 - 00:00  |  Presenting Author(s): Sureyya Sarihan

      • Abstract

      Loading...

    • +

      P20.05 - Oesophageal Dose Predicts on Treatment Toxicity in Patients Receiving Concurrent Chemo-Radiotherapy for Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Cameron Angus Keogh

      • Abstract

      Loading...

    • +

      P20.06 - Dosimetric Comparison of the Real and Virtual Plans in Non-Small Cell Lung Cancer Patients Treated With Respiratory Motion Management

      00:00 - 00:00  |  Presenting Author(s): Sureyya Sarihan

      • Abstract

      Loading...

  • +

    P21 - Locoregional and Oligometastatic Disease - Treatment of Locally Advanced NSCLC

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Locoregional and Oligometastatic Disease
    • +

      P21.01 - Phase I Study of Carboplatin/Nab-Paclitaxel and Concurrent TRT in Elderly Patients with Unresectable Locally Advanced NSCLC

      00:00 - 00:00  |  Presenting Author(s): Shota Omori

      • Abstract

      Loading...

    • +

      P21.02 - Incidence and Outcomes of Brain Metastases in Unresectable Stage III Patients with NSCLC Treated with Durvalumab after Chemoradiation

      00:00 - 00:00  |  Presenting Author(s): Sandip H Patel

      • Abstract

      Loading...

    • +

      P21.03 - Dutch Lung Cancer Audit-Radiotherapy: Real-World Data on Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy Only

      00:00 - 00:00  |  Presenting Author(s): Liselotte Van Bockel

      • Abstract

      Loading...

    • +

      P21.04 - Comparing Outcomes for Patients Receiving Chemoradiation Followed by Surgery vs. Immune Checkpoint Inhibitors in Non Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Turja Chakrabarti

      • Abstract

      Loading...

    • +

      P21.05 - Overall Survival by PD-L1 Status in Stage III NSCLC Following Implementation of Durvalumab: The Real-World Application of PACIFIC

      00:00 - 00:00  |  Presenting Author(s): Shelley Kuang

      • Abstract

      Loading...

    • +

      P21.06 - Patterns of Post-Progression Treatment and Impact of Subsequent Immunotherapy in Stage III Unresectable Non-Small Cell Lung Cancer Patients

      00:00 - 00:00  |  Presenting Author(s): Sarah Shin

      • Abstract

      Loading...

    • +

      P21.07 - Immune-Related Adverse Events with Durvalumab Consolidation in a Real-World Cohort of Patients with Non–Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenting Author(s): Gabriela Bravo Montenegro

      • Abstract

      Loading...

    • +

      P21.08 - Durvalumab Consolidation Following Chemoradiation for Unresectable Non-Small Cell Lung Cancer: A “Real-World” Experience.

      00:00 - 00:00  |  Presenting Author(s): Claire Griffiths

      • Abstract

      Loading...

    • +

      P21.09 - Does Duration of Maintenance Durvalumab Matter? Relationship between Length of Durvalumab Therapy and PFS.

      00:00 - 00:00  |  Presenting Author(s): Kamya Sankar

      • Abstract

      Loading...

    • +

      P21.10 - Real-World Treatment Patterns in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA trial)

      00:00 - 00:00  |  Presenting Author(s): Ligang Xing

      • Abstract

      Loading...

    • +

      P21.11 - Durvalumab after Concurrent cChemotherapy and High-Dose Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenting Author(s): Yosef Landman

      • Abstract

      Loading...

    • +

      P21.12 - An Observational Study of Treatment Outcome in Stage III Lung Cancer Patients in Taiwan: KINDLE study

      00:00 - 00:00  |  Presenting Author(s): Po-Lan Su

      • Abstract

      Loading...

    • +

      P21.13 - Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program

      00:00 - 00:00  |  Presenting Author(s): Florencia Tsou

      • Abstract

      Loading...

    • +

      P21.14 - The Promising role of Chemo-Immunotherapy in Non-Small Cell Lung Cancer Neoadjuvant Setting

      00:00 - 00:00  |  Presenting Author(s): Helena Bote

      • Abstract

      Loading...

    • +

      P21.15 - Sparing Preserved Lobes to Reduce Lung Dose for Operable IIIA NSCLC Patients Treated with Neoadjuvant Chemoradiotherapy

      00:00 - 00:00  |  Presenting Author(s): Hengle Gu

      • Abstract

      Loading...

    • +

      P21.16 - Do Patients who Underwent Lung Resection for Non-Small Cell Lung Cancer and Skip-N2 Metastases Show Better Survival?

      00:00 - 00:00  |  Presenting Author(s): Alejandra Libreros

      • Abstract

      Loading...

    • +

      P21.17 - Pneumonectomy for Locally Advanced Non-Small Cell Lung Cancer after Neoadjuvant Concurrent Chemo-Radiation Therapy

      00:00 - 00:00  |  Presenting Author(s): Kazunori Okabe

      • Abstract

      Loading...

  • +

    P22 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Case Reports

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      P22.01 - A Case of Intimal Sarcoma with Osteosarcomatous Differentiation

      00:00 - 00:00  |  Presenting Author(s): Etsuko Satoh

      • Abstract

      Loading...

    • +

      P22.02 - Outcome of Heart Rupture Repair During Huge Mediastinal Mass Resection

      00:00 - 00:00  |  Presenting Author(s): riad Amin Abdeljalil

      • Abstract

      Loading...

    • +

      P22.03 - Not Every FDG Avid Spot is Tumor

      00:00 - 00:00  |  Presenting Author(s): Isabelle Opitz

      • Abstract

      Loading...

    • +

      P22.04 - Lung Metastasis of Thyroid Transcription Factor 1 Positive Endometrioid Carcinoma; A Case Report

      00:00 - 00:00  |  Presenting Author(s): Masao Saito

      • Abstract

      Loading...

    • +

      P22.05 - Chest Wall and Diaphragm Reconstruction; a Technique not well Established in Literature

      00:00 - 00:00  |  Presenting Author(s): riad Amin Abdeljalil

      • Abstract

      Loading...

    • +

      P22.06 - A Large Solitary Fibrous Tumor of the Pleura Causing Paraneoplastic Hypoglycemia

      00:00 - 00:00  |  Presenting Author(s): Kohei Hashimoto

      • Abstract

      Loading...

    • +

      P22.07 - Nivolumab Immunotherapy as a Promising Therapy in Relapsed Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Sara Costa-Martins

      • Abstract

      Loading...

    • +

      P22.08 - Paraganglioma of the Anterior Mediastinum.

      00:00 - 00:00  |  Presenting Author(s): Motohisa Shibata

      • Abstract

      Loading...

  • +

    P23 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Esophageal Cancer and Rare Tumors

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      P23.01 - “Multidisciplinary Approach for the Management of Primary Tracheal Carcinoma”- Institutional Experience of 9 Bangladeshi Cases.

      00:00 - 00:00  |  Presenting Author(s): Qamruzzaman Chowdhury

      • Abstract

      Loading...

    • +

      P23.02 - Clinicopathological and Prognostic Features of 67 Cases With Pulmonary Sarcomatoid Carcinoma: An 18-Year Single Center Experience

      00:00 - 00:00  |  Presenting Author(s): Adnan Aydıner

      • Abstract

      Loading...

    • +

      P23.03 - The New Therapy on Esophageal Leiomyosarcoma in the Upper Esophagus

      00:00 - 00:00  |  Presenting Author(s): Chun-wei Xu

      • Abstract

      Loading...

    • +

      P23.04 - Primary Pulmonary Myxoid Sarcoma with EWSR1 Rearrangement: A Case Report

      00:00 - 00:00  |  Presenting Author(s): Mai Nishina

      • Abstract

      Loading...

  • +

    P24 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Mesothelioma Clinical and Trials in Progress

    • 00:00 - 01:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      P24.01 - Entire Pleural Intensity-Modulated Radiotherapy in a Neoadjuvant Setting for Resectable Malignant Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Yeonsil Kim

      • Abstract

      Loading...

    • +

      P24.03 - A Multicenter Randomized Phase III Trial of Dendritic Cell Maintenance Therapy After Chemotherapy in Mesothelioma; Denim Trial

      00:00 - 00:00  |  Presenting Author(s): Robert Anton Belderbos

      • Abstract

      Loading...

    • +

      P24.04 - Outcome of Neoadjuvant or Adjuvant Radiotherapy in Multimodality Setting with EPP for Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Alireza Hoda

      • Abstract

      Loading...

    • +

      P24.05 - Malignant Mesothelioma Related to Environmental Asbestos Exposure in a Rural Area: 30-year Follow-up

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P24.06 - Real World use of Cisplatin and Carboplatin Based Therapy in Patients with Malignant Pleural Mesothelioma (MPM)

      00:00 - 00:00  |  Presenting Author(s): Susana Cedres

      • Abstract

      Loading...

    • +

      P24.07 - Nivolumab and Ipilimumab +/- UV1 Vaccination as 2nd Line Treatment in Patients with Malignant Mesothelioma (the NIPU-Study)

      00:00 - 00:00  |  Presenting Author(s): Åslaug Helland

      • Abstract

      Loading...

    • +

      P24.08 - Radiological Response to TTFields Plus Chemotherapy for Malignant Pleural Mesothelioma from the Phase 2 STELLAR Trial

      00:00 - 00:00  |  Presenting Author(s): Federica Grosso

      • Abstract

      Loading...

    • +

      P24.09 - Pooled Safety Analysis of Clinical Trials Delivering Tumor Treating Fields (TTFields) to the Upper Torso

      00:00 - 00:00  |  Presenting Author(s): Federica Grosso

      • Abstract

      Loading...

  • +

    P25 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Mesothelioma Preclinical, Prognostic and Predictive Factors

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      P25.01 - Metabolic Characterization of Drug Resistance to Antifolate in Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Yuzo Sato

      • Abstract

      Loading...

    • +

      P25.02 - Lymph Node Metastasis of Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Aki Katarina Kobayashi

      • Abstract

      Loading...

    • +

      P25.03 - Novel Diagnosis Technique for Identification of Asbestos Fibres in Mesothelioma Samples using LA-ICP-MS Imaging

      00:00 - 00:00  |  Presenting Author(s): Oana Maria Voloaca

      • Abstract

      Loading...

    • +

      P25.04 - The Role of miRs in Determining the Response to Chemotherapy in MPM Patients Treated with Chemotherapy

      00:00 - 00:00

      • Abstract

      Loading...

    • +

      P25.05 - The Brims Decision Tree Model for Prognosis in a UK Malignant Mesothelioma Group

      00:00 - 00:00  |  Presenting Author(s): Avinash Aujayeb

      • Abstract

      Loading...

    • +

      P25.06 - Malignant Pleural Mesothelioma: Patient Characteristics, Treatments and Outcomes from a Spanish Center

      00:00 - 00:00  |  Presenting Author(s): Yago Garitaonaindía

      • Abstract

      Loading...

    • +

      P25.07 - Nutritional Risk Status Predicts Outcomes of Mexican Patients with Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Saul Campos-Gomez

      • Abstract

      Loading...

    • +

      P25.08 - National Organisational Audit of Specialist Mesothelioma Service and Support Provision for the United Kingdom

      00:00 - 00:00  |  Presenting Author(s): Susan Harden

      • Abstract

      Loading...

    • +

      P25.09 - Effectiveness of Tumor Treating Fields plus Cisplatin/Pemetrexed Combination in Mesothelioma, in Vitro and in Vivo

      00:00 - 00:00  |  Presenting Author(s): Moshe Giladi

      • Abstract

      Loading...

    • +

      P25.10 - Computational Simulations on Safety of Tumor Treating Fields Delivered to the Lungs in Mesothelioma and NSCLC

      00:00 - 00:00  |  Presenting Author(s): Ze'ev Bomzon

      • Abstract

      Loading...

    • +

      P25.11 - Evaluation of the Safety of Tumor Treating Fields (TTFields) Application to the Torso – in Vivo Studies

      00:00 - 00:00  |  Presenting Author(s): Moshe Giladi

      • Abstract

      Loading...

    • +

      P25.12 - The Vienna Mesothelioma Inflammation Score (VMIS) is Independently Associated with Overall Survival in Malignant Pleural Mesothelioma

      00:00 - 00:00  |  Presenting Author(s): Berta Mosleh

      • Abstract

      Abstract not provided

  • +

    P26 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Thymic Malignancies

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      P26.01 - Survival Impact of Adjuvant Postoperative Radiation Therapy (PORT) in Locally Advanced Thymic Carcinoma (TC): An Up-To-Date Meta-Analysis

      00:00 - 00:00  |  Presenting Author(s): Philip A. Haddad

      • Abstract

      Loading...

    • +

      P26.02 - The Impact of Clinicopathologic Factors on the Overall Survival of Thymic Neuroendocrine Tumors (TNET): A Pooled Analysis

      00:00 - 00:00  |  Presenting Author(s): Philip A. Haddad

      • Abstract

      Loading...

    • +

      P26.03 - The Impact of Postoperative Radiation Therapy on the Overall Survival of Resected Stage II Thymoma: An Up-to-date Meta-Analysis

      00:00 - 00:00  |  Presenting Author(s): Philip A. Haddad

      • Abstract

      Loading...

    • +

      P26.04 - Correlation of Somatostatin Receptor 2 Expression, DOTATATE scan and Octreotide Treatment in Thymic Epithelial Tumors

      00:00 - 00:00  |  Presenting Author(s): Anja C Roden

      • Abstract

      Loading...

    • +

      P26.05 - Comprehensive Genomic Sequencing in Thymic Epithelial Tumors: Identification of Multiple Poor Prognosis Biomarkers in Chinese Patients

      00:00 - 00:00  |  Presenting Author(s): Baohui Han

      • Abstract

      Loading...

    • +

      P26.06 - High frequency of Fatal Immune Checkpoint Inhibitor Associated Myocarditis in B2/B3 Thymoma Patients

      00:00 - 00:00  |  Presenting Author(s): Yue-Li Sun

      • Abstract

      Loading...

    • +

      P26.07 - Video-Assisted Thoracoscopic Surgery for Stage I Thymoma: Short-Term Outcomes and Appropriate Indications

      00:00 - 00:00  |  Presenting Author(s): Takahiro Suzuki

      • Abstract

      Loading...

    • +

      P26.08 - Postoperative Course of Thymoma with Myasthenia Gravis.

      00:00 - 00:00  |  Presenting Author(s): Fumihiko Hoshi

      • Abstract

      Loading...

    • +

      P26.09 - Is Thymomectomy alone through Video-Assisted Thoracic Surgery Appropriate for Clinical Stage I (T1N0M0) Thymoma 5cm or Less?

      00:00 - 00:00  |  Presenting Author(s): Kazuo Nakagawa

      • Abstract

      Loading...

    • +

      P26.10 - Molecular Characterization of Patients with Thymoma and Thymic Carcinoma

      00:00 - 00:00  |  Presenting Author(s): Xun Yang

      • Abstract

      Loading...

  • +

    P27 - Nursing and Allied Health Professionals - Symptom Management

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Nursing and Allied Health Professionals
    • +

      P27.01 - Multidisciplinary Management of Lung Cancer Patients Presenting with Oropharyngeal Dysphagia

      00:00 - 00:00  |  Presenting Author(s): Abigail Esther Camps

      • Abstract

      Loading...

    • +

      P27.02 - Symptom Burden and Referral to Allied Health Professionals at time of Diagnosis for Patients with Malignant Pleural Mesothelioma.

      00:00 - 00:00  |  Presenting Author(s): Faye Dickinson

      • Abstract

      Loading...

  • +

    P28 - Nursing and Allied Health Professionals - Regional Roles of Nurses and Allied Health Professionals

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Nursing and Allied Health Professionals
    • +

      P28.01 - The Clinical Pharmacist as a Member of a Multidisciplinary Team for Lung Cancer Patients Assistance

      00:00 - 00:00  |  Presenting Author(s): Gisele Fraga Moreira

      • Abstract

      Loading...

    • +

      P28.02 - Individualized Nutritional Management in Patients Eligible for Thoracic Surgery Experience of a Chest Tumor Center in Brazil

      00:00 - 00:00  |  Presenting Author(s): Imanuely Borchardt Gonçalves

      • Abstract

      Loading...

    • +

      P28.03 - An Autoethnographic Study Exploring the Role of the Lung Cancer Nurse Specialist in the National Optimal Lung Cancer Pathway

      00:00 - 00:00  |  Presenting Author(s): Alice Bobat

      • Abstract

      Loading...